A David promoter with Goliath strength
- PMID: 24832942
- DOI: 10.1182/blood-2014-04-565507
A David promoter with Goliath strength
Abstract
In this issue of Blood, Nair et al report on a computationally derived hepatocyte-specific cis-regulatory module (HS-CRM8) to accomplish high tissue-specific expression in gene therapy for hemophilia. When HS-CRM8 is introduced upstream of a minimal liver-specific promoter in an adenoassociated virus (AAV) that expresses a codon-optimized hyperactive human factor IX (FIX) mutant (FIX Padua), it provides a >1 log increase in systemic FIX protein levels and supraphysiological activity over a range of vector doses.
Comment on
-
Computationally designed liver-specific transcriptional modules and hyperactive factor IX improve hepatic gene therapy.Blood. 2014 May 15;123(20):3195-9. doi: 10.1182/blood-2013-10-534032. Epub 2014 Mar 17. Blood. 2014. PMID: 24637359 Free PMC article.